<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">33332476</PMID><DateCompleted><Year>2021</Year><Month>03</Month><Day>08</Day></DateCompleted><DateRevised><Year>2021</Year><Month>03</Month><Day>08</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1932-6203</ISSN><JournalIssue CitedMedium="Internet"><Volume>15</Volume><Issue>12</Issue><PubDate><Year>2020</Year></PubDate></JournalIssue><Title>PloS one</Title><ISOAbbreviation>PLoS One</ISOAbbreviation></Journal><ArticleTitle>A multistationary loop model of ALS unveils critical molecular interactions involving mitochondria and glucose metabolism.</ArticleTitle><Pagination><StartPage>e0244234</StartPage><MedlinePgn>e0244234</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e0244234</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0244234</ELocationID><Abstract><AbstractText>Amyotrophic lateral sclerosis (ALS) is a poor-prognosis disease with puzzling pathogenesis and inconclusive treatments. We develop a mathematical model of ALS based on a system of interactive feedback loops, focusing on the mutant SOD1G93A mouse. Misfolded mutant SOD1 aggregates in motor neuron (MN) mitochondria and triggers a first loop characterized by oxidative phosphorylation impairment, AMP kinase over-activation, 6-phosphofructo-2-kinase (PFK3) rise, glucose metabolism shift from pentose phosphate pathway (PPP) to glycolysis, cell redox unbalance, and further worsening of mitochondrial dysfunction. Oxidative stress then triggers a second loop, involving the excitotoxic glutamatergic cascade, with cytosolic Ca2+ overload, increase of PFK3 expression, and further metabolic shift from PPP to glycolysis. Finally, cytosolic Ca2+ rise is also detrimental to mitochondria and oxidative phosphorylation, thus closing a third loop. These three loops are overlapped and positive (including an even number of inhibitory steps), hence they form a candidate multistationary (bistable) system. To describe the system dynamics, we model the interactions among the functional agents with differential equations. The system turns out to admit two stable equilibria: the healthy state, with high oxidative phosphorylation and preferential PPP, and the pathological state, with AMP kinase activation, PFK3 over expression, oxidative stress, excitotoxicity and MN degeneration. We demonstrate that the loop system is monotone: all functional agents consistently act toward the healthy or pathological condition, depending on low or high mutant SOD1 input. We also highlight that molecular interactions involving PFK3 are crucial, as their deletion disrupts the system's bistability leading to a single healthy equilibrium point. Hence, our mathematical model unveils that promising ALS management strategies should be targeted to mechanisms that keep low PFK3 expression and activity within MNs.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Burlando</LastName><ForeName>Bruno</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0001-7545-0311</Identifier><AffiliationInfo><Affiliation>Department of Pharmacy, University of Genova, Genova, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Milanese</LastName><ForeName>Marco</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0003-3384-0666</Identifier><AffiliationInfo><Affiliation>Department of Pharmacy, University of Genova, Genova, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Giordano</LastName><ForeName>Giulia</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0002-8600-1738</Identifier><AffiliationInfo><Affiliation>Department of Industrial Engineering, University of Trento, Trento, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Delft Center for Systems and Control, Delft University of Technology, Delft, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bonifacino</LastName><ForeName>Tiziana</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Pharmacy, University of Genova, Genova, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ravera</LastName><ForeName>Silvia</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-0803-1042</Identifier><AffiliationInfo><Affiliation>Department of Experimental Medicine, University of Genova, Genova, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Blanchini</LastName><ForeName>Franco</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Dipartimento di Scienze Matematiche, Informatiche e Fisiche, University of Udine, Udine, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bonanno</LastName><ForeName>Giambattista</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Pharmacy, University of Genova, Genova, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>IRCCS-Ospedale Policlinico San Martino, Genova, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>12</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS One</MedlineTA><NlmUniqueID>101285081</NlmUniqueID><ISSNLinking>1932-6203</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D000072105">Superoxide Dismutase-1</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.11.31</RegistryNumber><NameOfSubstance UI="D055372">AMP-Activated Protein Kinases</NameOfSubstance></Chemical><Chemical><RegistryNumber>IY9XDZ35W2</RegistryNumber><NameOfSubstance UI="D005947">Glucose</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D055372" MajorTopicYN="N">AMP-Activated Protein Kinases</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="Y">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005947" MajorTopicYN="N">Glucose</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006019" MajorTopicYN="N">Glycolysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018345" MajorTopicYN="N">Mice, Knockout</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008928" MajorTopicYN="N">Mitochondria</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008962" MajorTopicYN="Y">Models, Theoretical</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="Y">Mutation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010085" MajorTopicYN="N">Oxidative Phosphorylation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018384" MajorTopicYN="N">Oxidative Stress</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000072105" MajorTopicYN="N">Superoxide Dismutase-1</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors have declared that no competing interests exist.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>8</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>12</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>12</Month><Day>17</Day><Hour>17</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>12</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>3</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33332476</ArticleId><ArticleId IdType="pmc">PMC7746301</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0244234</ArticleId><ArticleId IdType="pii">PONE-D-20-26823</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Zarei S, Carr K, Reiley L, Diaz K, Guerra O, Altamirano PF, et al. A comprehensive review of amyotrophic lateral sclerosis. Surg Neurol Int. 2015;6:171 Epub 2015/12/03. 10.4103/2152-7806.169561</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/2152-7806.169561</ArticleId><ArticleId IdType="pmc">PMC4653353</ArticleId><ArticleId IdType="pubmed">26629397</ArticleId></ArticleIdList></Reference><Reference><Citation>de Carvalho M, Dengler R, Eisen A, England JD, Kaji R, Kimura J, et al. Electrodiagnostic criteria for diagnosis of ALS. Clin Neurophysiol. 2008;119(3):497&#x2013;503. Epub 2008/01/01. 10.1016/j.clinph.2007.09.143 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinph.2007.09.143</ArticleId><ArticleId IdType="pubmed">18164242</ArticleId></ArticleIdList></Reference><Reference><Citation>Dervishi I, Ozdinler PH. Incorporating upper motor neuron health in ALS drug discovery. Drug Discov Today. 2018;23(3):696&#x2013;703. Epub 2018/01/15. 10.1016/j.drudis.2018.01.027</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.drudis.2018.01.027</ArticleId><ArticleId IdType="pmc">PMC5849515</ArticleId><ArticleId IdType="pubmed">29331501</ArticleId></ArticleIdList></Reference><Reference><Citation>Swinnen B, Robberecht W. The phenotypic variability of amyotrophic lateral sclerosis. Nat Rev Neurol. 2014;10(11):661&#x2013;70. Epub 2014/10/15. 10.1038/nrneurol.2014.184 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2014.184</ArticleId><ArticleId IdType="pubmed">25311585</ArticleId></ArticleIdList></Reference><Reference><Citation>Gurney ME. The use of transgenic mouse models of amyotrophic lateral sclerosis in preclinical drug studies. J Neurol Sci. 1997;152 Suppl 1:S67&#x2013;73. Epub 1998/01/07. 10.1016/s0022-510x(97)00247-5 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0022-510x(97)00247-5</ArticleId><ArticleId IdType="pubmed">9419057</ArticleId></ArticleIdList></Reference><Reference><Citation>Bozzo F, Mirra A, Carri MT. Oxidative stress and mitochondrial damage in the pathogenesis of ALS: New perspectives. Neuroscience letters. 2017;636:3&#x2013;8. Epub 2016/05/07. 10.1016/j.neulet.2016.04.065 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2016.04.065</ArticleId><ArticleId IdType="pubmed">27150074</ArticleId></ArticleIdList></Reference><Reference><Citation>Bilsland LG, Sahai E, Kelly G, Golding M, Greensmith L, Schiavo G. Deficits in axonal transport precede ALS symptoms in vivo. Proc Natl Acad Sci U S A. 2010;107(47):20523&#x2013;8. Epub 2010/11/10. 10.1073/pnas.1006869107</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1006869107</ArticleId><ArticleId IdType="pmc">PMC2996651</ArticleId><ArticleId IdType="pubmed">21059924</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin CL, Bristol LA, Jin L, Dykes-Hoberg M, Crawford T, Clawson L, et al. Aberrant RNA processing in a neurodegenerative disease: the cause for absent EAAT2, a glutamate transporter, in amyotrophic lateral sclerosis. Neuron. 1998;20(3):589&#x2013;602. Epub 1998/04/16. 10.1016/s0896-6273(00)80997-6 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0896-6273(00)80997-6</ArticleId><ArticleId IdType="pubmed">9539131</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor AA, Fournier C, Polak M, Wang L, Zach N, Keymer M, et al. Predicting disease progression in amyotrophic lateral sclerosis. Ann Clin Transl Neurol. 2016;3(11):866&#x2013;75. Epub 2016/11/16. 10.1002/acn3.348</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acn3.348</ArticleId><ArticleId IdType="pmc">PMC5099532</ArticleId><ArticleId IdType="pubmed">27844032</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonifacino T, Musazzi L, Milanese M, Seguini M, Marte A, Gallia E, et al. Altered mechanisms underlying the abnormal glutamate release in amyotrophic lateral sclerosis at a pre-symptomatic stage of the disease. Neurobiol Dis. 2016;95:122&#x2013;33. Epub 2016/07/19. 10.1016/j.nbd.2016.07.011 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2016.07.011</ArticleId><ArticleId IdType="pubmed">27425885</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamanaka K, Boillee S, Roberts EA, Garcia ML, McAlonis-Downes M, Mikse OR, et al. Mutant SOD1 in cell types other than motor neurons and oligodendrocytes accelerates onset of disease in ALS mice. Proc Natl Acad Sci U S A. 2008;105(21):7594&#x2013;9. Epub 2008/05/22. 10.1073/pnas.0802556105</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0802556105</ArticleId><ArticleId IdType="pmc">PMC2396671</ArticleId><ArticleId IdType="pubmed">18492803</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamanaka K, Komine O. The multi-dimensional roles of astrocytes in ALS. Neurosci Res. 2018;126:31&#x2013;8. Epub 2017/10/22. 10.1016/j.neures.2017.09.011 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neures.2017.09.011</ArticleId><ArticleId IdType="pubmed">29054467</ArticleId></ArticleIdList></Reference><Reference><Citation>Geloso MC, Corvino V, Marchese E, Serrano A, Michetti F, D'Ambrosi N. The Dual Role of Microglia in ALS: Mechanisms and Therapeutic Approaches. Front Aging Neurosci. 2017;9:242 Epub 2017/08/10. 10.3389/fnagi.2017.00242</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2017.00242</ArticleId><ArticleId IdType="pmc">PMC5524666</ArticleId><ArticleId IdType="pubmed">28790913</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoye ML, Regan MR, Jensen LA, Lake AM, Reddy LV, Vidensky S, et al. Motor neuron-derived microRNAs cause astrocyte dysfunction in amyotrophic lateral sclerosis. Brain. 2018;141(9):2561&#x2013;75. Epub 2018/07/15. 10.1093/brain/awy182</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awy182</ArticleId><ArticleId IdType="pmc">PMC6113638</ArticleId><ArticleId IdType="pubmed">30007309</ArticleId></ArticleIdList></Reference><Reference><Citation>Madji Hounoum B, Mavel S, Coque E, Patin F, Vourc'h P, Marouillat S, et al. Wildtype motoneurons, ALS-Linked SOD1 mutation and glutamate profoundly modify astrocyte metabolism and lactate shuttling. Glia. 2017;65(4):592&#x2013;605. Epub 2017/02/01. 10.1002/glia.23114 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.23114</ArticleId><ArticleId IdType="pubmed">28139855</ArticleId></ArticleIdList></Reference><Reference><Citation>Mejzini R, Flynn LL, Pitout IL, Fletcher S, Wilton SD, Akkari PA. ALS Genetics, Mechanisms, and Therapeutics: Where Are We Now? Front Neurosci. 2019;13:1310 Epub 2019/12/24. 10.3389/fnins.2019.01310</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2019.01310</ArticleId><ArticleId IdType="pmc">PMC6909825</ArticleId><ArticleId IdType="pubmed">31866818</ArticleId></ArticleIdList></Reference><Reference><Citation>Ravera S, Bonifacino T, Bartolucci M, Milanese M, Gallia E, Provenzano F, et al. Characterization of the Mitochondrial Aerobic Metabolism in the Pre- and Perisynaptic Districts of the SOD1(G93A) Mouse Model of Amyotrophic Lateral Sclerosis. Mol Neurobiol. 2018;55(12):9220&#x2013;33. Epub 2018/04/16. 10.1007/s12035-018-1059-z .</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-018-1059-z</ArticleId><ArticleId IdType="pubmed">29656361</ArticleId></ArticleIdList></Reference><Reference><Citation>Ravera S, Torazza C, Bonifacino T, Provenzano F, Rebosio C, Milanese M, et al. Altered glucose catabolism in the presynaptic and perisynaptic compartments of SOD1(G93A) mouse spinal cord and motor cortex indicates that mitochondria are the site of bioenergetic imbalance in ALS. J Neurochem. 2019;151(3):336&#x2013;50. Epub 2019/07/10. 10.1111/jnc.14819 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jnc.14819</ArticleId><ArticleId IdType="pubmed">31282572</ArticleId></ArticleIdList></Reference><Reference><Citation>Blanchini F, Franco E, Giordano G. A structural classification of candidate oscillatory and multistationary biochemical systems. Bull Math Biol. 2014;76(10):2542&#x2013;69. Epub 2014/09/19. 10.1007/s11538-014-0023-y .</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11538-014-0023-y</ArticleId><ArticleId IdType="pubmed">25230803</ArticleId></ArticleIdList></Reference><Reference><Citation>Muyderman H, Chen T. Mitochondrial dysfunction in amyotrophic lateral sclerosis&#x2014;a valid pharmacological target? Br J Pharmacol. 2014;171(8):2191&#x2013;205. Epub 2013/10/24. 10.1111/bph.12476</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bph.12476</ArticleId><ArticleId IdType="pmc">PMC3976630</ArticleId><ArticleId IdType="pubmed">24148000</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu J, Lillo C, Jonsson PA, Vande Velde C, Ward CM, Miller TM, et al. Toxicity of familial ALS-linked SOD1 mutants from selective recruitment to spinal mitochondria. Neuron. 2004;43(1):5&#x2013;17. Epub 2004/07/06. 10.1016/j.neuron.2004.06.016 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2004.06.016</ArticleId><ArticleId IdType="pubmed">15233913</ArticleId></ArticleIdList></Reference><Reference><Citation>Pasinelli P, Belford ME, Lennon N, Bacskai BJ, Hyman BT, Trotti D, et al. Amyotrophic lateral sclerosis-associated SOD1 mutant proteins bind and aggregate with Bcl-2 in spinal cord mitochondria. Neuron. 2004;43(1):19&#x2013;30. Epub 2004/07/06. 10.1016/j.neuron.2004.06.021 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2004.06.021</ArticleId><ArticleId IdType="pubmed">15233914</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodriguez-Rodriguez P, Fernandez E, Almeida A, Bolanos JP. Excitotoxic stimulus stabilizes PFKFB3 causing pentose-phosphate pathway to glycolysis switch and neurodegeneration. Cell Death Differ. 2012;19(10):1582&#x2013;9. Epub 2012/03/17. 10.1038/cdd.2012.33</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cdd.2012.33</ArticleId><ArticleId IdType="pmc">PMC3438489</ArticleId><ArticleId IdType="pubmed">22421967</ArticleId></ArticleIdList></Reference><Reference><Citation>Vandoorne T, De Bock K, Van Den Bosch L. Energy metabolism in ALS: an underappreciated opportunity? Acta Neuropathol. 2018;135(4):489&#x2013;509. Epub 2018/03/20. 10.1007/s00401-018-1835-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-018-1835-x</ArticleId><ArticleId IdType="pmc">PMC5978930</ArticleId><ArticleId IdType="pubmed">29549424</ArticleId></ArticleIdList></Reference><Reference><Citation>Hardie DG, Carling D. The AMP-activated protein kinase&#x2014;fuel gauge of the mammalian cell? Eur J Biochem. 1997;246(2):259&#x2013;73. Epub 1997/06/01. 10.1111/j.1432-1033.1997.00259.x .</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1432-1033.1997.00259.x</ArticleId><ArticleId IdType="pubmed">9208914</ArticleId></ArticleIdList></Reference><Reference><Citation>Perera ND, Turner BJ. AMPK Signalling and Defective Energy Metabolism in Amyotrophic Lateral Sclerosis. Neurochem Res. 2016;41(3):544&#x2013;53. Epub 2015/07/24. 10.1007/s11064-015-1665-3 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11064-015-1665-3</ArticleId><ArticleId IdType="pubmed">26202426</ArticleId></ArticleIdList></Reference><Reference><Citation>Hawley SA, Gadalla AE, Olsen GS, Hardie DG. The antidiabetic drug metformin activates the AMP-activated protein kinase cascade via an adenine nucleotide-independent mechanism. Diabetes. 2002;51(8):2420&#x2013;5. Epub 2002/07/30. 10.2337/diabetes.51.8.2420 .</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/diabetes.51.8.2420</ArticleId><ArticleId IdType="pubmed">12145153</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaneb HM, Sharp PS, Rahmani-Kondori N, Wells DJ. Metformin treatment has no beneficial effect in a dose-response survival study in the SOD1(G93A) mouse model of ALS and is harmful in female mice. PLoS One. 2011;6(9):e24189 Epub 2011/09/13. 10.1371/journal.pone.0024189</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0024189</ArticleId><ArticleId IdType="pmc">PMC3164704</ArticleId><ArticleId IdType="pubmed">21909419</ArticleId></ArticleIdList></Reference><Reference><Citation>Marsin AS, Bertrand L, Rider MH, Deprez J, Beauloye C, Vincent MF, et al. Phosphorylation and activation of heart PFK-2 by AMPK has a role in the stimulation of glycolysis during ischaemia. Curr Biol. 2000;10(20):1247&#x2013;55. Epub 2000/11/09. 10.1016/s0960-9822(00)00742-9 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0960-9822(00)00742-9</ArticleId><ArticleId IdType="pubmed">11069105</ArticleId></ArticleIdList></Reference><Reference><Citation>Herrero-Mendez A, Almeida A, Fernandez E, Maestre C, Moncada S, Bolanos JP. The bioenergetic and antioxidant status of neurons is controlled by continuous degradation of a key glycolytic enzyme by APC/C-Cdh1. Nat Cell Biol. 2009;11(6):747&#x2013;52. Epub 2009/05/19. 10.1038/ncb1881 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncb1881</ArticleId><ArticleId IdType="pubmed">19448625</ArticleId></ArticleIdList></Reference><Reference><Citation>Schousboe A, Scafidi S, Bak LK, Waagepetersen HS, McKenna MC. Glutamate metabolism in the brain focusing on astrocytes. Adv Neurobiol. 2014;11:13&#x2013;30. Epub 2014/09/23. 10.1007/978-3-319-08894-5_2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-3-319-08894-5_2</ArticleId><ArticleId IdType="pmc">PMC4667713</ArticleId><ArticleId IdType="pubmed">25236722</ArticleId></ArticleIdList></Reference><Reference><Citation>Rothstein JD. Excitotoxicity and neurodegeneration in amyotrophic lateral sclerosis. Clin Neurosci. 1995;3(6):348&#x2013;59. Epub 1995/01/01. .</Citation><ArticleIdList><ArticleId IdType="pubmed">9021256</ArticleId></ArticleIdList></Reference><Reference><Citation>Rao SD, Yin HZ, Weiss JH. Disruption of glial glutamate transport by reactive oxygen species produced in motor neurons. J Neurosci. 2003;23(7):2627&#x2013;33. Epub 2003/04/10. 10.1523/JNEUROSCI.23-07-02627.2003</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.23-07-02627.2003</ArticleId><ArticleId IdType="pmc">PMC6742077</ArticleId><ArticleId IdType="pubmed">12684448</ArticleId></ArticleIdList></Reference><Reference><Citation>Stifanese R, Averna M, De Tullio R, Pedrazzi M, Beccaria F, Salamino F, et al. Adaptive modifications in the calpain/calpastatin system in brain cells after persistent alteration in Ca2+ homeostasis. J Biol Chem. 2010;285(1):631&#x2013;43. Epub 2009/11/03. 10.1074/jbc.M109.031674</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M109.031674</ArticleId><ArticleId IdType="pmc">PMC2804211</ArticleId><ArticleId IdType="pubmed">19880516</ArticleId></ArticleIdList></Reference><Reference><Citation>Stifanese R, Averna M, De Tullio R, Pedrazzi M, Milanese M, Bonifacino T, et al. Role of calpain-1 in the early phase of experimental ALS. Arch Biochem Biophys. 2014;562:1&#x2013;8. Epub 2014/08/26. 10.1016/j.abb.2014.08.006 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.abb.2014.08.006</ArticleId><ArticleId IdType="pubmed">25151305</ArticleId></ArticleIdList></Reference><Reference><Citation>Su SC, Tsai LH. Cyclin-dependent kinases in brain development and disease. Annu Rev Cell Dev Biol. 2011;27:465&#x2013;91. Epub 2011/07/12. 10.1146/annurev-cellbio-092910-154023 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-cellbio-092910-154023</ArticleId><ArticleId IdType="pubmed">21740229</ArticleId></ArticleIdList></Reference><Reference><Citation>Dhariwala FA, Rajadhyaksha MS. An unusual member of the Cdk family: Cdk5. Cell Mol Neurobiol. 2008;28(3):351&#x2013;69. Epub 2008/01/10. 10.1007/s10571-007-9242-1 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10571-007-9242-1</ArticleId><ArticleId IdType="pubmed">18183483</ArticleId></ArticleIdList></Reference><Reference><Citation>Hall MC, Warren EN, Borchers CH. Multi-kinase phosphorylation of the APC/C activator Cdh1 revealed by mass spectrometry. Cell Cycle. 2004;3(10):1278&#x2013;84. Epub 2004/10/07. 10.4161/cc.3.10.1153 .</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/cc.3.10.1153</ArticleId><ArticleId IdType="pubmed">15467459</ArticleId></ArticleIdList></Reference><Reference><Citation>Maestre C, Delgado-Esteban M, Gomez-Sanchez JC, Bolanos JP, Almeida A. Cdk5 phosphorylates Cdh1 and modulates cyclin B1 stability in excitotoxicity. EMBO J. 2008;27(20):2736&#x2013;45. Epub 2008/09/27. 10.1038/emboj.2008.195</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/emboj.2008.195</ArticleId><ArticleId IdType="pmc">PMC2572178</ArticleId><ArticleId IdType="pubmed">18818692</ArticleId></ArticleIdList></Reference><Reference><Citation>Carriedo SG, Sensi SL, Yin HZ, Weiss JH. AMPA exposures induce mitochondrial Ca(2+) overload and ROS generation in spinal motor neurons in vitro. J Neurosci. 2000;20(1):240&#x2013;50. Epub 2000/01/11. 10.1523/JNEUROSCI.20-01-00240.2000</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.20-01-00240.2000</ArticleId><ArticleId IdType="pmc">PMC6774118</ArticleId><ArticleId IdType="pubmed">10627601</ArticleId></ArticleIdList></Reference><Reference><Citation>Nicholls DG. Mitochondrial dysfunction and glutamate excitotoxicity studied in primary neuronal cultures. Curr Mol Med. 2004;4(2):149&#x2013;77. Epub 2004/03/23. 10.2174/1566524043479239 .</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1566524043479239</ArticleId><ArticleId IdType="pubmed">15032711</ArticleId></ArticleIdList></Reference><Reference><Citation>Barber SC, Shaw PJ. Oxidative stress in ALS: key role in motor neuron injury and therapeutic target. Free Radic Biol Med. 2010;48(5):629&#x2013;41. Epub 2009/12/09. 10.1016/j.freeradbiomed.2009.11.018 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.freeradbiomed.2009.11.018</ArticleId><ArticleId IdType="pubmed">19969067</ArticleId></ArticleIdList></Reference><Reference><Citation>Islam MT. Oxidative stress and mitochondrial dysfunction-linked neurodegenerative disorders. Neurol Res. 2017;39(1):73&#x2013;82. Epub 2016/11/05. 10.1080/01616412.2016.1251711 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/01616412.2016.1251711</ArticleId><ArticleId IdType="pubmed">27809706</ArticleId></ArticleIdList></Reference><Reference><Citation>Korshunov SS, Skulachev VP, Starkov AA. High protonic potential actuates a mechanism of production of reactive oxygen species in mitochondria. FEBS Lett. 1997;416(1):15&#x2013;8. Epub 1997/11/22. 10.1016/s0014-5793(97)01159-9 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0014-5793(97)01159-9</ArticleId><ArticleId IdType="pubmed">9369223</ArticleId></ArticleIdList></Reference><Reference><Citation>Voit EO. The best models of metabolism. Wiley Interdiscip Rev Syst Biol Med. 2017;9(6). Epub 2017/05/26. 10.1002/wsbm.1391</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/wsbm.1391</ArticleId><ArticleId IdType="pmc">PMC5643013</ArticleId><ArticleId IdType="pubmed">28544810</ArticleId></ArticleIdList></Reference><Reference><Citation>Gesztelyi R, Zsuga J, Kemeny-Beke A, Varga B, Juhasz B A. T. The Hill equation and the origin of quantitative pharmacology. Archive for History of Exact Sciences. 2012;66:427&#x2013;38.</Citation></Reference><Reference><Citation>Giordano G, Cuba Samaniego C, Franco E, Blanchini F. Computing the structural influence matrix for biological systems. J Math Biol. 2016;72(7):1927&#x2013;58. Epub 2015/09/24. 10.1007/s00285-015-0933-9 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00285-015-0933-9</ArticleId><ArticleId IdType="pubmed">26395779</ArticleId></ArticleIdList></Reference><Reference><Citation>Marsin AS, Bouzin C, Bertrand L, Hue L. The stimulation of glycolysis by hypoxia in activated monocytes is mediated by AMP-activated protein kinase and inducible 6-phosphofructo-2-kinase. J Biol Chem. 2002;277(34):30778&#x2013;83. Epub 2002/06/18. 10.1074/jbc.M205213200 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M205213200</ArticleId><ArticleId IdType="pubmed">12065600</ArticleId></ArticleIdList></Reference><Reference><Citation>Holecek V, Rokyta R. Possible etiology and treatment of amyotrophic lateral sclerosis. Neuro Endocrinol Lett. 2018;38(8):528&#x2013;31. Epub 2018/03/06. .</Citation><ArticleIdList><ArticleId IdType="pubmed">29504729</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhattacharya S, Conolly RB, Kaminski NE, Thomas RS, Andersen ME, Zhang Q. A bistable switch underlying B-cell differentiation and its disruption by the environmental contaminant 2,3,7,8-tetrachlorodibenzo-p-dioxin. Toxicol Sci. 2010;115(1):51&#x2013;65. Epub 2010/02/04. 10.1093/toxsci/kfq035</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/toxsci/kfq035</ArticleId><ArticleId IdType="pmc">PMC2855357</ArticleId><ArticleId IdType="pubmed">20123757</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng J, Yang M, Chen Y, Chen X, Liu J, Sun S, et al. FUS Interacts with HSP60 to Promote Mitochondrial Damage. PLoS Genet. 2015;11(9):e1005357 Epub 2015/09/04. 10.1371/journal.pgen.1005357</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pgen.1005357</ArticleId><ArticleId IdType="pmc">PMC4559378</ArticleId><ArticleId IdType="pubmed">26335776</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang P, Deng J, Dong J, Liu J, Bigio EH, Mesulam M, et al. TDP-43 induces mitochondrial damage and activates the mitochondrial unfolded protein response. PLoS Genet. 2019;15(5):e1007947 Epub 2019/05/18. 10.1371/journal.pgen.1007947</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pgen.1007947</ArticleId><ArticleId IdType="pmc">PMC6524796</ArticleId><ArticleId IdType="pubmed">31100073</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi SY, Lopez-Gonzalez R, Krishnan G, Phillips HL, Li AN, Seeley WW, et al. C9ORF72-ALS/FTD-associated poly(GR) binds Atp5a1 and compromises mitochondrial function in vivo. Nat Neurosci. 2019;22(6):851&#x2013;62. Epub 2019/05/16. 10.1038/s41593-019-0397-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-019-0397-0</ArticleId><ArticleId IdType="pmc">PMC6800116</ArticleId><ArticleId IdType="pubmed">31086314</ArticleId></ArticleIdList></Reference><Reference><Citation>Pun S, Santos AF, Saxena S, Xu L, Caroni P. Selective vulnerability and pruning of phasic motoneuron axons in motoneuron disease alleviated by CNTF. Nat Neurosci. 2006;9(3):408&#x2013;19. Epub 2006/02/14. 10.1038/nn1653 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn1653</ArticleId><ArticleId IdType="pubmed">16474388</ArticleId></ArticleIdList></Reference><Reference><Citation>Hegedus J, Putman CT, Tyreman N, Gordon T. Preferential motor unit loss in the SOD1 G93A transgenic mouse model of amyotrophic lateral sclerosis. J Physiol. 2008;586(14):3337&#x2013;51. Epub 2008/05/10. 10.1113/jphysiol.2007.149286</Citation><ArticleIdList><ArticleId IdType="doi">10.1113/jphysiol.2007.149286</ArticleId><ArticleId IdType="pmc">PMC2538809</ArticleId><ArticleId IdType="pubmed">18467368</ArticleId></ArticleIdList></Reference><Reference><Citation>Le Masson G, Przedborski S, Abbott LF. A computational model of motor neuron degeneration. Neuron. 2014;83(4):975&#x2013;88. Epub 2014/08/05. 10.1016/j.neuron.2014.07.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2014.07.001</ArticleId><ArticleId IdType="pmc">PMC4167823</ArticleId><ArticleId IdType="pubmed">25088365</ArticleId></ArticleIdList></Reference><Reference><Citation>Medinas DB, Rozas P, Martinez Traub F, Woehlbier U, Brown RH, Bosco DA, et al. Endoplasmic reticulum stress leads to accumulation of wild-type SOD1 aggregates associated with sporadic amyotrophic lateral sclerosis. Proc Natl Acad Sci U S A. 2018;115(32):8209&#x2013;14. Epub 2018/07/25. 10.1073/pnas.1801109115</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1801109115</ArticleId><ArticleId IdType="pmc">PMC6094144</ArticleId><ArticleId IdType="pubmed">30038021</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo C, Sun L, Chen X, Zhang D. Oxidative stress, mitochondrial damage and neurodegenerative diseases. Neural Regen Res. 2013;8(21):2003&#x2013;14. Epub 2013/07/25. 10.3969/j.issn.1673-5374.2013.21.009</Citation><ArticleIdList><ArticleId IdType="doi">10.3969/j.issn.1673-5374.2013.21.009</ArticleId><ArticleId IdType="pmc">PMC4145906</ArticleId><ArticleId IdType="pubmed">25206509</ArticleId></ArticleIdList></Reference><Reference><Citation>Tonnies E, Trushina E. Oxidative Stress, Synaptic Dysfunction, and Alzheimer's Disease. J Alzheimers Dis. 2017;57(4):1105&#x2013;21. Epub 2017/01/07. 10.3233/JAD-161088</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-161088</ArticleId><ArticleId IdType="pmc">PMC5409043</ArticleId><ArticleId IdType="pubmed">28059794</ArticleId></ArticleIdList></Reference><Reference><Citation>Doig AJ. Positive Feedback Loops in Alzheimer's Disease: The Alzheimer's Feedback Hypothesis. J Alzheimers Dis. 2018;66(1):25&#x2013;36. Epub 2018/10/05. 10.3233/JAD-180583</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-180583</ArticleId><ArticleId IdType="pmc">PMC6484277</ArticleId><ArticleId IdType="pubmed">30282364</ArticleId></ArticleIdList></Reference><Reference><Citation>Giza CC, Hovda DA. The Neurometabolic Cascade of Concussion. J Athl Train. 2001;36(3):228&#x2013;35. Epub 2003/08/26.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC155411</ArticleId><ArticleId IdType="pubmed">12937489</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>